HilleVax, Inc. - Common Stock

Share · US43157M1027 · HLVX (XNAS)

Overview

Analyst Grade Summary

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

n/a

Share Float & Liquidity

Free Float 45,36 %

Shares Float 22,74 M

Shares Outstanding 50,13 M

Company Profile for HilleVax, Inc. - Common Stock Share

HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.

AI Analysis of HilleVax, Inc. - Common Stock

Click any analysis below to get instant AI insights from finAgent

Latest AI Analyses of HilleVax, Inc. - Common Stock

No AI threads available for this company yet.

Company Data

Name HilleVax, Inc. - Common Stock

Company HilleVax, Inc.

Symbol HLVX

Website https://www.hillevax.com

Primary Exchange

NASDAQ

ISIN US43157M1027

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Robert M. Hershberg

Market Capitalization 105 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 75 State Street, 02109 Boston

IPO Date 2022-04-29

Ticker Symbols

Name	Symbol
NASDAQ	HLVX

More Shares

Investors who hold HilleVax, Inc. - Common Stock also have the following shares in their portfolio:

CREDIT AGRICOLE CORP & INV BANK CALL RTE LKD INT NTS 24/11/25 Bond

KRED.F.WIED.19/29 ANL DL Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog